Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Excess maternal androgens can cause heart problems in offspring.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Adrenal disorders often cause high blood pressure in young people.

The risks of testosterone implants in women outweigh the benefits.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Spironolactone can reduce hair growth in women with hirsutism.

A score of 6 or less is recommended to diagnose hirsutism in Colombian women.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Spironolactone plus finasteride reduces hirsutism more effectively.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Individualized treatment improves symptoms and quality of life for women with PCOS.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.